Eli Lilly and Company (LLY)

Eli Lilly Revenue

Eli Lilly had revenue of $12.73B in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly had annual revenue of $45.04B with 32.00% growth.

• Revenue (ttm): $49.00B
• Revenue Growth: +36.38%
• P/S Ratio: 13.59
• Revenue / Employee: $1,042,621
• Employees: 47,000
• Market Cap: 680.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	45.04B	10.92B	32.00%
Dec 31, 2023	34.12B	5.58B	19.56%
Dec 31, 2022	28.54B	223.00M	0.79%
Dec 31, 2021	28.32B	3.78B	15.40%
Dec 31, 2020	24.54B	2.22B	9.95%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.